AMH (Anti-Müllerian hormone) is a key biomarker for ovarian reserve, reflecting the number of remaining eggs. It is widely used in fertility diagnostics to predict response to ovarian stimulation during assisted reproduction. A low AMH level may indicate diminished reserve but does not equate to infertility. AMH itself does not improve fertility; it is a diagnostic tool, not a treatment. Evidence for its predictive value is human-strong, but with caveats: levels vary with age, cycle phase, and assay methodology. Direct-to-consumer tests may overstate the significance of a single measurement. A comprehensive fertility workup should include additional hormones, cycle tracking, and partner factors. Given the lack of specific context here, the answer remains conservative: AMH aids assessment, not enhancement, of fertility.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-9a497c4e8fdee1b2ed9618a6